Sergio Vallejo, Devalingam Mahalingam, Colin Court, Norma Ketchum, Jonathan Gelfond, Joel Michalek, Sukeshi Patel Arora. Published: June 20, 2024. DOI:https://doi.org/10.1016/j.jgo.2024.101816
Krishmita Siwakoti, Christian Harmon, Mustafa Al-Obaidi, Arnab Basu, Grant R. Williams. Published: June 20, 2024. DOI:https://doi.org/10.1016/j.jgo.2024.101812
Juanping Hu, Jiarong Lan, Guangxing Xu. Published: May 31, 2024. DOI:https://doi.org/10.1016/j.jgo.2024.101804
The SIOG Nursing & Allied Health organised a webinar on the Oncology care providers’ perceptions and anticipated barriers regarding the use of geriatric assessment in routine clinic practice: A mixed-methods study. https://vimeo.com/951125414?share=copy
Fausto Petrelli, Lorenzo Dottorini, Agostina De Stefani, Ivano Vavassori, Andrea Luciani. Published:May 26, 2024. DOI:https://doi.org/10.1016/j.jgo.2024.101792.
Khushboo Nusrat, Rafay Khan, Syed Husain Farhan, Shanza Malik, Neha Saleem Paryani, Mohammad Arham Siddiq, Roha Saeed Memon, Hafsa Jawaid, Ishaque Hameed. Published: May 23, 2024. DOI: https://doi.org/10.1016/j.jgo.2024.101797
INTRODUCTION Colorectal cancer is responsible for the second highest mortality among all cancer types and primarily affects adults aged 70 years or older. Due to the aging global population, the number of older adults with cancer, including colorectal cancer, is rapidly increasing. Although the majority of patients with metastatic colorectal cancer (mCRC) are older than 70 years, there are very few clinical trials specifically focused on this large patient group. The investigator-initiated randomized phase II NORDIC9-study prospectively assessed an approach for older patients with mCRC who were not considered candidates for full-dose combination treatment, comparing reduced-dose combination therapy to full-dose single-agent chemotherapy. NORDIC9 included 160 patients from four Nordic countries between March 2015 and October 2017. The study established that reduced-dose combination chemotherapy resulted in significantly prolonged progression-free survival, with a trend towards prolonged overall survival, fewer toxicities, and fewer hospital admissions compared to full-dose monotherapy. Additionally, patients receiving reduced-dose [...]
Tanya M. Wildes, Kathryn Fabbiano. Published: May 15, 2024. DOI: https://doi.org/10.1016/j.jgo.2024.101794.
Mayu Mizuta, Shin Kondo, Akihiko Hibi, Yuya Ueda, Daisuke Makiura, Rei Ono, Toshihiro Akisue. Published: May 04, 2024. DOI: https://doi.org/10.1016/j.jgo.2024.101782
Christiaan D.A. Meerkerk, Cheryl P. Bruijnen, Frederiek van den Bos, Marielle H. Emmelot-Vonk, Remco de Bree. Open Access Published: April 27, 2024. DOI: https://doi.org/10.1016/j.jgo.2024.101776
International Society of Geriatric Oncology
P/A Comptabilis
9 route des Jeunes
1227 Les Acacias - Switzerland
In Special Consultative Status with the United Nations Economic and Social Council (ECOSOC).
